Introduction
============

*Serratia* species are ubiquitous in the environment, and are found in water and soil as well as associated with plants, insects, humans, and other animals. The genus *Serratia* belongs to the family *Enterobacteriaceae* and comprises at least 14 species with two subspecies ([@evu160-B40]). Among these *Serratia* species, *S. marcescens* is the one most commonly associated with human infections. Originally considered as nonpathogenic, it is now recognized as an important nosocomial pathogen capable of causing urinary tract infections ([@evu160-B41]; [@evu160-B52]; [@evu160-B65]), bloodstream infections including endocarditis ([@evu160-B28]), and many other types of infections ([@evu160-B74]). Several potential virulence factors of *S. marcescens* have been identified, including hemolysin ([@evu160-B19]; [@evu160-B64]), proteases ([@evu160-B38]; [@evu160-B39]), lipopolysaccharide (LPS) ([@evu160-B42]), fimbriae ([@evu160-B54]), and siderophores ([@evu160-B36]). The pathogenicity and genomic plasticity of members of this species are, however, yet to be fully understood.

One other important feature of *S. marcescens* as a nosocomial pathogen is its intrinsic and acquired resistance to antimicrobial agents. Many of the clinical isolates of this organism carry chromosomal and plasmid-encoded genetic determinants specifying resistance to a wide range of antibiotics ([@evu160-B40]) including extended-spectrum beta-lactamase (ESBL) or metallo beta-lactamase (MBL). For example, surveys in Poland (1996--2000) in two hospitals showed 19% (67/354) of *S. marcescens* isolates produced ESBL ([@evu160-B50]). Similarly in Taiwan (2001--2002), 12% (15/123) were ESBL producers and the 30-day mortality rate of patients with ESBL-producing *S. marcescens* was 33% ([@evu160-B7]). MBL-producing *S. marcescens* are clinically more problematic because they show a high level resistance to a wider range of beta-lactams including carbapenem. A representative MBL enzyme, IMP-1, was first seen in a *S. marcescens* clinical isolate in 1991 in Japan ([@evu160-B53]). Since then various types of MBL have been identified in many *S. marcescens* strains ([@evu160-B70]), including those causing outbreaks ([@evu160-B22]; [@evu160-B49]).

Here, we report and compare the complete genome sequences of two *S. marcescens* strains; a clinical isolate that showed a high level multidrug resistance (strain SM39) and a spontaneous streptomycin-resistant mutant derived from the strain Db10 originally isolated from a moribund fly (strain Db11). Our analysis reveals a possible core genome of *S. marcescens* and accessory genomes specific to each strain, providing insights into the high virulence potential of the clinical isolate. We found that the extremely high level of multidrug resistance of strain SM39 was due to the presence of the plasmid pSMC1, which encodes MBL and several other drug resistance determinants. We propose a scenario for the origin and evolution of pSMC1, based on its genomic features.

Materials and Methods
=====================

*S. marcescens* Strains, Culture Media, and Growth Conditions
-------------------------------------------------------------

Strain SM39 was isolated from a septicemic patient in Japan in 1999 ([@evu160-B48]). Strain Db11, a kind gift from Dominique Ferrandon, is a spontaneous streptomycin-resistant derivative of strain Db10 which was isolated from a moribund *Drosophila melanogaster* in Sweden ([@evu160-B15]). It is available, together with Db10, from the *Caenorhabditis* Genetics Center (<http://www.cbs.umn.edu/CGC>, last accessed August 6, 2014). For routine bacterial cultivation, the strains were aerobically grown at 37 °C in Luria--Bertani (LB) broth with shaking or on LB agar plates.

Genome Sequencing, Gene Prediction, and Annotation
--------------------------------------------------

Genomic DNA was prepared from overnight cultures of the two strains using the Genomic-tip 100/G and Genomic DNA buffer set (Qiagen, Inc.) according to the manufacturer's instructions. The genome of SM39 was shotgun sequenced to approximately 12-fold coverage from 102,218 end sequences of two genomic shotgun libraries based on pUC118 and pCC1BAC with average insert sizes of 3 and 10 kb, respectively. The genome of Db11 was shotgun sequenced to approximately 10-fold coverage from 90,142 end sequences from multiple shotgun libraries: pMAQ1Sac\_*Bst*XI (with insert sizes of 5.5--6, 9--10, and 10--12 kb), pUC19 (with insert sizes of 1.4--2 and 2--2.8 kb), pOTWI2 (with insert sizes of 3--3.3 and 2--2.8 kb), and M13mp18 (with insert sizes of 1--1.4, 0.4--0.8, 1--1.4, and 0.5--1 kb). This was supplemented by approximately 0.2-fold coverage from 1,713 end sequences derived from large insert fosmid libraries: pBACe3.6\_*Bam*HI with an insert size 18--23 kb. All sequencing was performed using big-dye terminator chemistry on ABI3730 or ABI3700 capillary automated sequencers (Applied Biosystems). All assemblies were generated using Phrap. All repeat regions, gaps and low quality regions were bridged using large insert fosmid libraries, read-pairs, or end-sequenced polymerase chain reaction (PCR) products. The sequences were manipulated to the community standard of "Finished" ([@evu160-B4]).

Nucleotide sequence position 1 of each chromosome was assigned according to that of published *Escherichia* *coli* genomes. Gene prediction and annotation were performed using Microbial Genome Annotation Pipeline ([@evu160-B66]), followed by manual curation on the basis of the results of BLASTP homology search against the public nonredundant protein database (<http://www.ncbi.nlm.nih.gov/>, last accessed August 6, 2014). The annotated genome sequences of SM39 and Db11 have been deposited to the DDBJ/EMBL/GenBank database under the accession numbers AP013063 for the SM39 chromosome, AP013064 for the pSMC1 plasmid of SM39, AP013065 for pSMC2 of SM39, and HG326223 for the Db11 chromosome.

Genome-Wide Comparative Analysis
--------------------------------

Intra- and interstrain clustering analyses of protein coding sequences (CDSs) were performed based on the results of all-to-all BLASTP analysis with a threshold of ≥90% amino acid sequence identity over ≥90% aligned length of the query sequence ([supplementary fig. S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1) online, for details). In Silico Molecular Cloning (InSilico Biology, Yokohama, Japan) was used for genome sequence comparison. The average nucleotide identity (ANI) was calculated using the JSpecies software ([@evu160-B60]). Multiple alignments of sequences were constructed using the ClustalW program ([@evu160-B68]) and a neighbor-joining tree was generated using the Tamura--Nei model in MEGA5 ([@evu160-B67]). Pathway analysis was performed using the KEGG (Kyoto Encyclopedia of Genes and Genomes) online database ([@evu160-B25]). Signal peptide-containing proteins were identified using the SignalP 4.1 server (<http://www.cbs.dtu.dk/services/SignalP/>, last accessed August 6, 2014) ([@evu160-B55]). For the interspecies comparison, following four genomes were used: *S. proteamaculans* strain 568 (GenBank accession number CP000826) and *S. plymuthica* strains AS9 (CP002773) ([@evu160-B51]) and 4Rx13 (CP006250) ([@evu160-B72]), which were all isolated from plants, and *S. odorifera* strain DSM4582 (from human sputum) (ADBY00000000).

Semiautomated Screen for Mutants with an Attenuated Virulence Using *Caenorhabditis* *elegans*
----------------------------------------------------------------------------------------------

A library of individual *S. marcescens* Db10 mini-Tn5Sm mutant clones was generated using standard methods. Using a COPAS Biosort (Union Biometrica, Boston), 30 L4 stage wild type (N2) worms were sorted into the wells of 96-well plates as previously described ([@evu160-B17]). Then, 30 µl of an overnight culture (30 °C in 200 µl LB with 100 µg/ml streptomycin in 96-well plates) of individual mutant clones was transferred to the worm-containing wells. Assay plates containing worms and bacteria were incubated at 25 °C with agitation, whereas overnight culture plates were kept at 4 °C. A duplicate assay was performed the following day, again with 30 L4 worms per well, using the same bacterial cultures. For this, bacterial cultures were warmed up from 4 °C to room temperature for at least an hour before use. For each assay and its duplicate, the number of worms alive in each well was scored each day for 5 days by examination with a dissecting microscope. Wells were scored as − (\<5 worms alive), + (5--9 alive), ++ (10--14 alive), and +++ (at least 15 alive). Mutants were considered attenuated when they scored either ++ after 3 days, or + after 4 or 5 days, and were subsequently assayed for worm killing on solid medium as previously described ([@evu160-B33]). The mini-Tn5-Sm insertion site in attenuated mutants was determined by direct genomic DNA sequencing (MilleGen, Labège, France) with primers JEP131 and JEP132 (5′-CGGCCGCACTTGTGTATAA-3′ and 5′-CTAGGCGGCCAGATCTGATCAA-3′, respectively).

Construction of KS3, a pSMC1-Cured Derivative of SM39
-----------------------------------------------------

Because the pSMC1 plasmid of SM39 is highly stable, we could not obtain SM39-derivatives that have spontaneously lost pSMC1. To obtain a pSMC1-cured derivative of SM39, we first deleted the *parABC* genes (pSMC1_53-55) of pSMC1 using a method described by [@evu160-B43]. The upstream and downstream *parABC*-flanking regions were amplified by PCR using primer pairs parAUF4/parAUR2 (5′-GGAATTCAGCTAGCTTCTAGATGACCAGAAA-3′ and 5′-CAGAGAACAACAAGATAGATTTTAGCCGCTAAA-3′) and parADF2/parADR3 (5′-GCTAAAATCTATCTTGTTGTTCTCTGTTATTCCC-3′ and 5′-CTCGAGCTCTGTGCGCATCGAGTT-3′), respectively. The PCR products were concatenated by fusion PCR with primers parAUF4 and parADR3. The concatenated DNA fragment was inserted into pLOI2223 to yield pPAR001, and then a *Not*I fragment of pMT5071, which encodes the Mob cassette, was inserted into pPAR001 to yield pPAR002. pPAR002 was mobilized conjugally from *E. coli* strain S17-1 to *S. marcescens* SM39. Transconjugants, in which pPAR002 was inserted into pSMC1 (the first recombination), were selected on BM2 plates containing 150 µg/ml of chloramphenicol (Cm) and sucrose-sensitive clones were further screened using sucrose (10%)-containing and sucrose-free LB plates. Insertion of pPAR002 into pSMC1 was confirmed by PCR, and then pPAR002 excision (with or without the *parABC* genes) was selected on sucrose LB plates. Cm-susceptible clones were screened by PCR for the loss of the *parABC* genes. SM39-derivatives cured of pSMC1 were sensitive to HgCl~2~ (16 µg/ml in LB plates). The loss of pSMC1 was finally confirmed by plasmid profiling, and one of these derivatives (designated as KS3) was used for further analysis. See [supplementary figure S2](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1) online, for the entire process and the composition of BM2 medium.

Antimicrobial Susceptibility Testing
------------------------------------

Minimum inhibitory concentrations (MICs) of strains SM39, KS3, and Db11 against 36 antimicrobial agents were determined by the usual 2-fold agar dilution technique with Mueller-Hinton II agar (Becton Dickinson Microbiology Systems, Cockeysville, MD) with an inoculum size of 10^4^ cells as described previously ([@evu160-B43]).

Results and Discussion
======================

Comparative Genomics of Human Clinical and Insect Pathogenic *S. marcescens* Strains SM39 and Db11
--------------------------------------------------------------------------------------------------

The chromosomes of SM39 and Db11 are similar in size, 5,225,577 and 5,113,802 bp, respectively, and gene number ([table 1](#evu160-T1){ref-type="table"} and [fig. 1](#evu160-F1){ref-type="fig"}*A*). SM39 carries two plasmids, pSMC1 (41,517 bp) and pSMC2 (58,929 bp). No extrachromosomal elements were found in Db11. Overall, the chromosomes of the two strains are highly conserved and essentially collinear, except for a large inversion of the *oriC* region flanked by rRNA operons ([fig. 1](#evu160-F1){ref-type="fig"}*B*). Surprisingly for members of the same species, the ANI between the conserved genomic regions of the two strains (4,391 kb) is only 95.1%. This can be compared with a figure of 97.0% for the ANI between two distantly related members of *E. coli*, strains K-12 and E2348/69. Despite this, the 16S rRNA genes of the two strains show 99.4% sequence identity, consistent with DB11 and SM39 being members of the same species ([@evu160-B27]; see also [supplementary fig. S3](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1) online). Further with a criterion of ≤90% nucleotide sequence identity and ≥5 kb length, we identified 44 genomic regions specific to SM39, totaling 628 kb (12% of the genome), and 39 specific regions (447 kb or 8.7% of the genome) for Db11 ([fig. 1](#evu160-F1){ref-type="fig"}*A*; see also [supplementary tables S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1) and [S2](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1) online). The relatively low ANI value for the two *S. marcescens* strains and the considerable amount of isolate-specific sequences may reflect the diversity of niches that this species can occupy. F[ig]{.smallcaps}. 1.---The chromosomes of *Serratia marcescens* strains SM39 and Db11. (*A*) Circular maps of the SM39 and Db11 chromosomes. From the outside in, the first circle shows the nucleotide sequence positions (in Mb), and the second circle shows the locations of strain-specific regions of ≥5 kb (purple: prophages and integrative elements; red: others) with an indication of their features and/or encoded products/functions (PP, prophages; IE, integrative elements; EPS, exopolysaccharide biosynthesis). The third and fourth circles show CDSs transcribed clockwise and anticlockwise, respectively (yellow: CDSs conserved in both strains, blue: CDSs specific to one strain), the fifth circle the rRNA operons, the sixth circle the G+C content, and the seventh circle the GC skew. (*B*) Dot plot presentation of DNA sequence homologies between the chromosomes. Locations of *ori* and seven rRNA operons (*rrn1--rrn*7) are indicated. Table 1Genomic Features of *Serratia marcescens* Strains SM39 and Db11StrainsSM39Db11Chromosome    Size (bp)5,225,5775,113,802    GC content (%)59.859.5    CDSs[^a^](#evu160-TF1){ref-type="table-fn"}4,866 (19)4,722 (15)    rRNA operons77    tRNAs8787    Prophages72    Integrative elements24    IS elements175Plasmid spSMC1pSMC2None    Size (bp)41,51758,929---    GC content (%)61.551.9---    CDSs[^a^](#evu160-TF1){ref-type="table-fn"}55 (4)72 (0)---    IS elements10---[^3]

To extend the analysis of unique and shared genes between the two strains, we performed a clustering analysis of the SM39 and Db11 CDSs using an all-against-all BLASTP approach (outlined in [supplementary fig. S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1) online). This showed that 3,970 genes (or gene families) were conserved in both strains with additional 860 SM39-specific and 728 Db11-specific genes ([fig. 2](#evu160-F2){ref-type="fig"}*A*). Functional classification of these genes based on the Cluster of Orthologous Groups (COG) categories indicated that genes belonging to "category L (replication, recombination, and repair)" and "category V (defense mechanisms)" are more highly represented in SM39 than in Db11 ([fig. 2](#evu160-F2){ref-type="fig"}*B*). These differences are largely attributable to the presence of more genes associated with lateral gene transfer in SM39 such as insertion sequence (IS) transposases and integrases (category L), and genes for restriction-modification systems and multidrug transport systems (category V). For example, SM39 carries a higher variety and number of IS elements: 18 compared with the 5 carried by Db11 ([table 1](#evu160-T1){ref-type="table"}). These IS elements were classified into 11 distinct types, nine of which represent novel IS elements. Eight types were found in SM39 and four in Db11, with only IS*Se5* being shared by both isolates ([supplementary table S3](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1) online). More prophages were also found in SM39 (seven) than in Db11 (only two), with none of the prophages and other integrative elements being shared by the two strains ([table 1](#evu160-T1){ref-type="table"} and [supplementary table S4](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1) online). F[ig]{.smallcaps}. 2.---Comparison of the gene contents of SM39 and Db11. (*A*) Venn diagram showing the numbers of conserved and strain-specific CDSs. (*B*) COG category-based functional analysis of each group of CDSs, the conserved and strain-specific CDSs. J: translation, ribosomal structure, and biogenesis; K: transcription; L: replication, recombination, and repair; D: cell cycle control, cell division chromosome partitioning; V: defense mechanisms; O: posttranslational modification, protein turnover, and chaperones; T: signal transduction mechanisms; M: cell wall/membrane/envelope biogenesis; U: intracellular trafficking, secretion, and vesicular transport; N: Cell motility; C: energy production and conversion; G: carbohydrate transport and metabolism; E: amino acid transport and metabolism; F: nucleotide transport and metabolism; H: coenzyme transport and metabolism; I: lipid transport and metabolism; P: inorganic ion transport and metabolism; Q: secondary metabolites biosynthesis, transport, and catabolism; R: general function prediction only; S: function unknown. (*C*) Conservation of each group of CDSs in four strains of other *Serratia* species (*S. proteamaculans* 568, *S. odorifera* DSM4582, *S. plymuthica* 4Rx13, and *S. plymuthica* AS9).

We further compared the *S. marcescens* gene sets with those of four sequenced strains from other *Serratia* species: *S. proteamaculans* strain 568 and *S. plymuthica* strains AS9 ([@evu160-B51]) and 4Rx13 ([@evu160-B72]), which were all isolated from plants, and *S. odorifera* strain DSM4582 (from human sputum). This showed that only 23% and 38% of the genes that we denoted as SM39- or Db11-specific had homologs in these isolates representing other *Serratia* species ([fig. 2](#evu160-F2){ref-type="fig"}*C*). In contrast, 71% (2,852 genes) of the 3,970 core genes shared by the two *S. marcescens* strains were conserved in all the four isolates representing other *Serratia* species. This suggests that, despite the genetic diversity of this genus (see [supplementary fig. S3](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1) online, for the phylogenetic relationship of these species in genus *Serratia*), there is a relatively large shared or core genome of 2,852 CDSs. This analysis also identified 358 genes that are conserved in the two *S. marcescens* strains but absent in other *Serratia* species. This group includes a number of genes related to pathogenicity in other bacteria (data not shown).

Common and Strain-Specific Metabolic Capabilities in *S. marcescens* SM39 and Db11
----------------------------------------------------------------------------------

Central metabolic pathways are well conserved between the two strains and characteristic of the species as a whole: Positive fermentation for sucrose and [d]{.smallcaps}-sorbitol, and negative for [d]{.smallcaps}- and [l]{.smallcaps}-arabinose, [l]{.smallcaps}-rhamnose, [d]{.smallcaps}-xylose and cellubiose. Not uncommonly, both isolates lack the genes for prodigiosin biosynthesis, the characteristic red pigment often associated with *S. marcescens* ([@evu160-B21]). The differences between the two isolates include, for carbohydrate metabolism, alternative pathways for [l]{.smallcaps}-ascorbate utilization; the *ula*-type encoded pathway is carried by SM39 (SM39_4088-4095) and the *sgb-*type by Db11 (SMDB11_3334-3337). Major differences in nitrogen metabolism are also observed between the two isolates: Unlike Db11, SM39 carries the *nrtABC* operon (SM39_1878-1880) encoding an ATP-binding cassette (ABC) transporter for nitrate/nitrite, the *nasAC* operon (SM39_1885 and SM39_1886) encoding a nitrate reductase, and the *nasB* gene (SM39_1884) encoding a nitrite reductase (all in the SM39_E18 region; [supplementary table S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1) online). Thus SM39 appears to have a potential capacity to utilize nitrate, which is present in urine, as a nitrogen source. Related to this, both SM39 and Db11 carry an operon necessary for the metabolism of allantoin but lack the *allB* gene encoding allantoinase ([@evu160-B11]). Allantoin is the principal nitrogen source in urine in most mammals. Humans and nonhuman primates, however, carry a genetic lesion, thus rather than allantoin, they accumulate urate that can be catabolized despite the loss of *allB*. Together, these genes could be associated with the potential capacity of *S. marcescens* strains to grow in urine and cause urinary tract infections in humans ([@evu160-B40]).

Diversity and Differential Evolution of the Potential Virulence of *S. marcescens* SM39 and Db11
------------------------------------------------------------------------------------------------

*Serratia* *marcescens* is well known for its ability to secrete numerous exoenzymes and other proteins. We identified many known or predicted secreted or surface-exposed proteins potentially related to virulence, most of which (30/40) are conserved in both strains ([supplementary table S5](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1) online).

### Surface Structures and Polysaccharides

Here again, the genomic analysis revealed conservation and specialization of the outer surface of the two sequenced strains. *Serratia* *marcescens* is characteristically motile, and both strains carry a complete *E. coli-*like gene set for the biosynthesis of flagella and for chemotaxis ([supplementary table S6](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1) online). These gene sets are highly conserved between SM39 and Db11, the exception being the *fliC* flagellin-encoding gene, which shows a remarkable sequence diversity (only 68.3% identity in the amino acid sequence). Variation in flagellin structure is linked with antigenic variation and differences in the helicity of the flagellum that in turn are associated with niche adaptation.

Both Db11 and SM39 possess multiple operons for the biosynthesis of chaperone--usher fimbriae associated with biofilm formation and attachment to biotic and abiotic surfaces ([@evu160-B35]; [@evu160-B63]). Among these, six are conserved in the two strains (two are significantly divergent in sequence), but three and four are specific to SM39 and Db11, respectively ([fig. 3](#evu160-F3){ref-type="fig"}). In addition, although both strains contain a complete set of type IV fimbriae-related genes ([@evu160-B61]; [@evu160-B31]; [@evu160-B73]) ([supplementary table S7](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1) online), only SM39 contains a homolog (SM39_0944) of *yagZ*/*ecpA*/*matB*, the gene for *E. coli* common pili (also known as Mat fimbriae) ([@evu160-B57]; [@evu160-B59]). F[ig]{.smallcaps}. 3.---Fimbriae operons identified in SM39 and Db11. The gene organization of the operons for biosynthesis of chaperone-usher fimbriae identified in SM39 and Db11 is shown. (*A*) Operons "conserved" between the two strains showing a high sequence identity (\>95% amino acid sequence identity for all gene products) and (*B*) genes in the "diversified" operons show low sequence identity (up to 86% amino acid sequence identity). Note that both strains contain a set of type IV fimbriae-related genes, orthologs of which have been identified of *Escherichia coli,* and that a homologue (SM39_0944) of *yagZ*/*ecpA*/*matB*, the gene for *E. coli* common pili (also known as Mat fimbriae) was found in SM39 but not in Db11.

Although the SM39 and Db11 LPS core polysaccharide biosynthesis gene clusters (the *waa* genes) are broadly similar, there is significant sequence divergence (25--71% amino acid sequence identity for the corresponding predicted proteins) in four orthologous genes (SM39_4551-4554 and SMDB11_4052-4055) in this cluster. These four genes encode two glycosyltransferases, a polymer ligase (WaaL), and an UDP-galactose-4-epimerase. Those of Db11 showed high similarity to those of *S. marcescens* strain N28b serovar O4 ([@evu160-B8]). These data suggest that at least two LPS core types exist in *S. marcescens.*

The gene cluster for O antigen biosynthesis was identified between the S-layer biosynthesis gene cluster and the *his* operon in both strains ([fig. 4](#evu160-F4){ref-type="fig"}). As expected, the gene contents of the loci significantly differ between the two strains; Db11 was serotyped conventionally as O28:K7, whereas SM39 was untypeable. There is also good evidence from the genome sequences that both strains carry a complete gene cluster for group 1 capsule polysaccharide (CPS) biosynthesis, equivalent to the colanic acid biosynthesis genes in *E. coli.* Differences in gene content in this region suggest, however, that the two strains produce different types of group 1 CPS ([fig. 4](#evu160-F4){ref-type="fig"}). This will need to be addressed experimentally in future studies. F[ig]{.smallcaps}. 4.---Comparison of the SM39 and Db11 genomic loci bearing exopolysaccharide biosynthesis gene clusters. The gene organization of the gene clusters for O antigen biosynthesis and for group 1 CPS biosynthesis is compared between SM39 (untypeable) and Db11 (O28:K7). The O antigen biosynthesis genes of SM39 and Db11 show high level of similarities to those of *Klebsiella pneumoniae* O8 and those of *K. pneumoniae* O5, respectively. The Db11 operon also has a high level of similarity to that of *Escherichia coli* O8 (Iguchi A, Iyoda S, Kikuchi T, Ogura Y, Katsura K, Ohnishi M, Hayashi T and Thomson NR, unpublished data), consistent with the cross-reactivity between *Serratia marcescens* O28*, K. pneumoniae* O5, and *E. coli* O8 antigens previously reported by [@evu160-B3].

### Secretion Systems and Secreted Proteins

One unexpected difference between Db11 and SM39 is the presence of a type II secretion system (T2SS) in SM39 but not in Db11 ([supplementary fig. S4](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1) online). The T2SS is a multiprotein secretion complex, present in a wide variety of organisms and frequently implicated in virulence ([@evu160-B29]). Although the substrates of the SM39 T2SS are unknown, it could well contribute to the virulence of SM39.

Multiple type V secretion systems (T5SSs) are present in SM39 and Db11. T5SSs include both autotransporters and two-partner systems ([@evu160-B20]; [@evu160-B24]). An archetypal example of a two-partner T5SS is ShlBA; the hemolysin ShlA is one of the known major virulence factors in *S. marcescens* ([@evu160-B19]). The *shlBA* operon is conserved in both strains. In contrast, three additional gene clusters, encoding two-partner systems with partial similarity to ShlA and other haemagglutinin-like proteins, were identified only in SM39 ([fig. 5](#evu160-F5){ref-type="fig"}). Two of these, SM39_2080-2077 and SM39_3145-3141, appear to encode contact-dependent inhibition (Cdi) systems. In such systems, CdiB is a translocator protein that assembles the large, hemagglutinin domain-containing CdiA passenger protein on the cell surface ([@evu160-B2]). Variable toxin domains are found at the C-terminus of CdiA (CdiA~Ct~), which mediate contact-dependent growth inhibition of competitor bacteria. Additionally, immunity proteins (CdiI) cognate to the CdiA~Ct~ are encoded downstream of CdiA. Both loci contain a typical *cdiBAI* arrangement. The SM39_3144 locus also includes an "orphan" CdiA~Ct~--CdiI paizr (SM39_3142-3141). Orphan CdiA~Ct~--CdiI pairs contain truncated CdiA C-termini thought to represent remnants or reservoirs of alternative toxin domains, which can be exchanged to provide new antibacterial capability ([@evu160-B56]). F[ig]{.smallcaps}. 5.---Gene clusters for hemolysin/hemagglutin-like two-partner Type V secretion systems identified in SM39 and Db11. (*A*) The gene organization of the gene clusters for hemolysin/hemagglutin-like two-partner systems in SM39 and Db11 is shown. TpsA components are the passenger proteins (including the ShlA hemolysin and CdiA proteins) and TpsB components are the cognate translocator proteins (including ShlB and CdiB proteins). Although the *shlBA* operon (image 1) is conserved in the two strains, three additional gene clusters were found only in SM39. Two of these, SM39_2080-2077 (image 3) and SM39_3145-3141 (image 4), based on homology, encode Cdi systems. In addition to CdiA and CdiB proteins, a third component conferring resistance to the C-terminal toxin domain of CdiA is encoded downstream of CdiA, the CdiI immunity protein (SM39_2078 and SM39_3143, respectively). A putative "orphan" CdiA C-terminus (including a distinct potential toxin domain) and cognate CdiI pair is encoded by SM39_3142-3141. The function of the third SM39-specific cluster, SM39_0386-0387 (image 2), is unknown. (*B*) Similarities between the TpsA hemolysin/hemagglutin-related proteins (amino acid sequence identity) are shown, with those newly identified in SM39 showing partial similarity to ShlA.

Both SM39 and Db11 contain Lip (lipase) and Has (hemophore) type I secretion systems ([@evu160-B26]), and both possess a single type VI secretion system (T6SS) conserved between the two strains ([supplementary fig. S5](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1) online). T6SS can be used by bacteria either to target eukaryotic cells as a direct virulence mechanism or to kill rival bacterial cells as a competitive fitness mechanism ([@evu160-B9]). The *S. marcescens* T6SS has been shown to have potent bacterial killing activity ([@evu160-B47]). Furthermore, six effectors (antibacterial toxins) secreted by this system have recently been identified in Db11, together with cognate immunity proteins that protect against self-toxicity ([@evu160-B14]; [@evu160-B16]). Of these, the Ssp1 and Ssp2 effectors, Tae4-family peptidoglycan amidases which attack the target cell wall, and associated Rap (Tai4) immunity proteins are encoded within the T6SS gene cluster ([supplementary fig. S5](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1) online). Overall, the T6SS gene clusters of Db11 and SM39 are very similar with some significant differences: Although the Ssp1--Rap1a effector--immunity pair is conserved, the "orphan" Rap1b immunity protein is missing from SM39 and Ssp2 has been replaced by a new effector--immunity pair, belonging to the same Tae4--Tai4 family but clearly distinct. This strongly suggests that the T6SS antibacterial activity of *S. marcescens* is highly specific and strain-dependent, as has been observed experimentally ([@evu160-B47]).

### Iron Uptake

Iron uptake is essential for bacterial growth within host organisms because iron is sequestered by the host ([@evu160-B1]). SM39 and Db11 possess multiple common sets of iron acquisition systems with only a few differences. Although some of the common systems are also found in other sequenced *Serratia* species ([supplementary table S8](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1) online), others, including a second gene cluster for siderophore synthesis, *fecIRA* and *fepBGDC* for transport of ferric compounds, and the *has* operon, are restricted to *S. marcescens*. These species-specific iron uptake systems might be associated with the higher virulence of *S. marcescens* compared with other species of the genus.

### Quorum-Sensing System

Quorum-sensing systems sense bacterial cell density and play important roles in regulating the behavior of bacterial population by controlling various biological processes, including pathogenicity. None of the three *N*-acyl homoserine lactone (AHL) quorum-sensing systems so far described in strains of *S. marcescens* (SwrI/SwrR \[[@evu160-B12]; [@evu160-B13]\], SpnI/SpnR \[[@evu160-B23]\], and SmaI/SmaR \[[@evu160-B10]\]) was found in SM39 or Db11. Instead, we identified a candidate SM39-specific AHL system comprising LuxI/LuxR family proteins (SM39_4838 and SM39_4837), which show a high similarity (about 80% amino acid sequence identity) to ExpR/ExpI of *Erwinia tasmaniensis* ([@evu160-B46]). In contrast, no AHL quorum-sensing system was found in Db11. These data indicate a remarkable variation in the AHL quorum-sensing system among *S. marcescens* strains.

Variation of Nonribosomal Peptide Synthetase-Dependent Secondary Metabolites and Weapons for Interbacterial Competition
-----------------------------------------------------------------------------------------------------------------------

Diffusible inhibitory molecules include antibiotics and bacteriocins (protein or peptide toxins targeting related organisms). SM39 and Db11 have one and two bacteriocins, respectively, not shared by the other, as well as two in common (including bacteriocin 28b).

An operon of six genes specific to Db11 (SMDB11_2293-2288, named *alb1--alb6*) encodes a hybrid nonribosomal peptide synthetase (NRPS)-polyketide synthase (PKS) enzyme, plus tailoring enzymes and a resistance-conferring efflux pump. This cluster was recently identified as required for the ability of Db10 to produce a diffusible antimicrobial compound and shown to direct the synthesis of a broad-spectrum antibiotic called althiomycin ([@evu160-B18]). Two predicted NRPS enzymes are found only in SM39 and may also be involved in biosynthesis of antimicrobial molecules. These variations, along with those in T6SS and Cdi systems, suggest that interbacterial competition in microbial communities is one of the important drivers of genomic diversity in *S. marcescens*.

NRPS-dependent molecules also have other roles. In Db11, SMDB11_3680, or SwrA, produces the biosurfactant Serrawettin W2 ([@evu160-B58]). In SM39, SM39_3884 shares only 56% identity with SwrA but, given that it is encoded in the same genomic locus and has a very similar domain organization, it probably synthesizes a related biosurfactant molecule. Three other NRPSs are shared by both strains, including two involved in synthesis of the two siderophores mentioned earlier.

In Vivo Screening Shows That Many Core *S. marcescens* or *Serratia* sp. Genes Are Involved in Virulence in an Invertebrate Model Host
--------------------------------------------------------------------------------------------------------------------------------------

Db10 was isolated from *D.* *melanogaster* ([@evu160-B15]), but it is pathogenic in several other infection models, including *C. elegans* and mice. Previous work has shown that there is a substantial overlap between the genes required for full virulence of *S.* *marcescens* during infection of flies and *C.* *elegans* ([@evu160-B33]). Thus, as the nematode is well-suited to automated screens ([@evu160-B34]; [@evu160-B17]), we used it to look for new *S.* *marcescens* virulence factors and to determine whether genes associated with virulence were within the shared or accessory gene sets. We constructed a mini-Tn*5*-Sm transposon mutant library in Db10 and assayed clones in a high-throughput screen to identify mutants with a reduced ability to kill *C. elegans*. From the 12,480 individual Db10-derived clones that were tested, 12 mutants (0.1% of all the mutants screened) were selected as showing the most robust reduction in virulence.

The mini-Tn*5*-Sm insertion site in each mutant was identified by sequencing and mapping to the genomic sequence of *S. marcescens* Db11 (for a complete list, see [supplementary table S9](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1) online). Of the 12 mutants, four loci had also been identified in a previous solid medium-based screen ([@evu160-B33]). These include those involved in O antigen biosynthesis and siderophore production. The availability of the complete sequence combined with recent findings ([@evu160-B47]; [@evu160-B14]; [@evu160-B16]) revealed a hitherto unsuspected contribution of a T6SS to the pathogenic capability of *S.* *marcescens*, either directly or by providing a competitive fitness advantage against other bacteria in vivo. The previously isolated mutants 22D9 and 7D1 ([@evu160-B33]) were found to correspond to SMDB11_2265 and SMDB11_2266, respectively, which are both T6SS immunity proteins, 8C7 to SMDB11_1112, a T6SS effector protein of unknown function, whereas the previously uncloned 23C11 corresponded to SMDB11_3455, a T6SS-related, minor Hcp homolog ([@evu160-B14]; [@evu160-B16]). As previously reported, this screen also led to the isolation of a mutant in the *swrA* gene responsible for the biosynthesis of the surfactant Serrawettin W2 ([@evu160-B58]). Additional mutants of interest include one containing an insert in a *wza* homolog, potentially involved in capsule biosynthesis, and three deficient in respiration (JESM266, JESM268, JESM271; [supplementary table S9](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1) online). None of these latter mutants showed a defect in growth under standard conditions. This raises the possibility that the nematode intestine represents a restrictive respiratory environment.

The combined results of this and the previously published screens ([@evu160-B33]) identified 30 loci important for the in vivo virulence of Db10 and/or Db11. Among the 30 genes, 22 are conserved in SM39. Of these, 11 are conserved in all of the four other *Serratia* strains analyzed ([supplementary table S9](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1) online). The proportions of virulence genes conserved between Db11 and SM39 (73%) and between this common set and the other *Serratia* strains (50%) are markedly lower than the equivalent proportions of the entire gene sets (84.5% and 71%, respectively). This presumably reflects the different tropisms of the different species and the host-specific nature of many virulence factors.

Origins of Antimicrobial Resistance in SM39 and Db11
----------------------------------------------------

### Intrinsic Resistance

A large number of genes related to antimicrobial resistance are encoded on the chromosomes of both Db11 and the clinical *S. marcescens* isolate SM39. As listed in [table 2](#evu160-T2){ref-type="table"}, we identified many efflux pumps belonging to five families: The ABC superfamily, the major facilitator superfamily (MFS), the multidrug and toxic-compound extrusion (MATE) family, the small multidrug resistance (SMR) family, and the resistance nodulation division (RND) family. Among these, only *smdAB* ([@evu160-B44]), *sdeAB* ([@evu160-B32]), *sdeXY* ([@evu160-B5]), *smfY* ([@evu160-B62]), and *ssmE* ([@evu160-B45]) had been characterized in previous studies. Most of the efflux pumps are shared by the two strains although a few are strain-specific. In addition, a class C beta-lactamase AmpC, two aminoglycoside acetyltransferases each having distinct substrate specificities, and a fosfomycin-inactivating enzyme (FosA) are encoded on the chromosomes of the two strains ([table 3](#evu160-T3){ref-type="table"}). Thus, the overall repertoire of the chromosomally encoded resistance genes is largely similar in both strains despite their different origins, and is highly conserved accounting for the high and broad intrinsic resistance of *S. marcescens* ([table 3](#evu160-T3){ref-type="table"}). One notable difference between the two strains is a mutation in the *gyrA* gene of the clinically isolated SM39, generating a S83R substitution and conferring resistance to quinolone ([@evu160-B71]). Table 2Drug Efflux Pumps Found in the Genomes of SM39 and Db11SM39 (SM39\_)Db11 (SMDB11\_)GeneIMP (SM39\_/SMDB11\_)MFP (SM39\_/SMDB11\_)OMPABC type    0414-04150354-0355*smdABsmdA, smdB*------    1134-11350964-0965*macABmacBmacA*---    1329-13311118-1120*etsABCetsBetsAetsC*    4783-47854552-4554---4784/45534783/4552---4785/4554------RND type    0448-04490369-0370*sdeXYsdeYsdeX*---    1281-12821059-1060---1281/10591282/1060---    1400-14011196-1197*sdeABsdeBsdeA*---    Not found1254A-1255A---SMDB11_1254ASMDB11_1255ASMDB11_1256    1913-1915Not found---SM39_1914SM39_1913SM39_1915[^a^](#evu160-TF2){ref-type="table-fn"}    1920-19221741-1743---1921/17421922/1743SMDB11_1741[^a^](#evu160-TF2){ref-type="table-fn"}    Not found1698-1699---SMDB11_1699SMDB11_1698---    1958Not found---SM39_1958------    31002891*acrDacrD*------    3162-31642945-2947*sdeCDEsdeD, sdeEsdeC*---MFS type    467390*fsrfsr*------    13511140*mdtGmdtG*------    18101629---1810/1629------    Not found1759*tetAtetA*------    21641961*smfYsmfY*------    22732069*mdtHmdtH*------    28192580*bcrbcr*------    31652948*mdtDmdtD*------    3343-33443133-3134*emrABemrBemrA*SMDB11_3132[^a^](#evu160-TF2){ref-type="table-fn"}    46224024*emrDemrD*------    43914201*mdfAmdfA*------    44974107---4497/4107------MATE type    16531463*mdtKmdtK*------    25982377---2598/2377------    39123713*dinFdinF*------SMR type    20351855*ssmE*2035/1855------    2237-22382032-2033*mdtJI*2237/2032------2238/2033------    46934462*sugE*4693/4462------    pSMC1_35Not found*qacE1qacE1*------    pSMC1_46Not found*qacE2qacE2*------[^4] Table 3Drug Resistance Profiles and Genetic Determinants Responsible for Each Resistance in Strains SM39, KS3, and Db11Antimicrobial Agents (Subclasses)MIC (mg/ml)Putative Resistance DeterminantSM39KS3[^a^](#evu160-TF4){ref-type="table-fn"}Db11On ChoromosomeOn pSMC1GeneSM39/KS3 (SM39\_)Db11 (SMDB11\_)Geneβ-Lactams    Piperacillin (PEN)822*ampC*17211530*bla*~CMY~*, bla*~IMP~    Faropenem (PEM)\>25644*ampC*17211530*bla*~CMY~*, bla*~IMP~    Cephalothin (1st CEP)\>256\>256\>256*ampC*17211530*bla*~CMY~*, bla*~IMP~    Cefuroxime (2nd CEP)\>256\>256\>256*ampC*17211530*bla*~CMY~*, bla*~IMP~    Cefmetazol (2nd CEP)\>2563216*ampC*17211530*bla*~CMY~*, bla*~IMP~    Cefotaxime (3rd CEP)\>2560.51---------*bla*~CMY~*, bla*~IMP~    Ceftazidime (3rd CEP)2560.251---------*bla*~CMY~*, bla*~IMP~    Ceftriaxone (3rd CEP)\>2560.50.25---------*bla*~CMY~*, bla*~IMP~    Latamoxef (3rd CEP)\>2560.250.125---------*bla*~CMY~*, bla*~IMP~    Cefbuperazone (3rd CEP)\>2560.50.5---------*bla*~CMY~*, bla*~IMP~    Cefotetan (3rd CEP)\>2560.50.5---------*bla*~CMY~*, bla*~IMP~    Cefpirome (4th CEP)320.250.25---------*bla*~CMY~*, bla*~IMP~    Cefepime (4th CEP)320.250.25---------*bla*~CMY~*, bla*~IMP~    Aztreonam (MONO)80.130.25---------*bla*~CMY~*, bla*~IMP~    Imipenem (CARB)160.50.5---------*bla*~IMP~    Meropenem (CARB)32≤0.03≤0.03---------*bla*~IMP~Aminoglycosides    Streptomycin\>1284\>128 [^b^](#evu160-TF5){ref-type="table-fn"}*acc(6)-Id*16931504*aadA*    Tobramycin1283232*aac(6′)-Ic*37583638*aadA*    Amikacin641616*aac(6′)-Ic*37583638*aadA*    Arbekacin641616*aac(6′)-Ic*37583638*aadA*    Kanamycin1283232*aac(6′)-Ic*37583638*aadA*    Spectinomycin\>5123216*aac(6′)-Ic*37583638*aadA*    Gentamycin1644---------*aadA*Quinolones    Levofloxacin440.25*gyrA*[^c^](#evu160-TF6){ref-type="table-fn"}\[+\] in 2886\[−\] in 2665---    Sparfloxacin440.5*gyrA*[^c^](#evu160-TF6){ref-type="table-fn"}\[+\] in 2886\[−\] in 2665---    Ciprofloxacin440.25*gyrA*[^c^](#evu160-TF6){ref-type="table-fn"}\[+\] in 2886\[−\] in 2665---    Tosufloxacin220.125*gyrA*[^c^](#evu160-TF6){ref-type="table-fn"}\[+\] in 2886\[−\] in 2665---Macrolides    Erythromycin128128128*macAB*1134_11350964_0965---    Josamycin\>512\>512\>512*macAB*1134_11350964_0965---Others    Tetracycline161664*tetA*Not found1759---    Rifampicin161616------------    Fosfomycin\>512\>512\>512*fosA*23062100---    Sulfamethoxazole\>128\>128\>128UnknownUnknown*sulI1/2*    Ethidium bromide\>512\>512\>512*ssmE*20351855*qacE1*/*2*    Benzalkonium chloride128128128------------    HgCl~2~3288---------*mer* operon[^5][^6][^7][^8]

### Acquired Antimicrobial Resistance Genes

Unlike Db11, SM39 carries two plasmids. The overall GC contents of the two plasmids differ significantly from the chromosome (∼59%): 61.5% for pSMC1 and 51.9% for pSMC2. The plasmid pSMC2 carries a set of genes for conjugation (the *tra* and *trb* genes), and although lacking *traJ* and *traT*, it can be transferred by conjugation from SM39 to *E. coli* K-12 strain x1037 Rif^r^ (data not shown). Although pSMC2 contains no gene related to virulence or drug resistance, pSMC1 carries an integron that contains the *aadA* gene encoding an aminoglycoside-3′-adenylyltransferase, the *bla*CMY-8 gene encoding a class C beta-lactamase which inactivates a much broader range of beta-lactams than the chromosomally encoded class C beta-lactamase (AmpC), and the *bla*IMP-1 gene encoding a metal beta-lactamase (MBL). In addition, pSMC1 contains two copies of the *qacE* gene, associated with resistance to a range of disinfectants ([@evu160-B30]), and two copies of the sulfonamide resistance gene (*sulI*) as well as a transposon encoding the *mer* operon for mercury resistance ([fig. 6](#evu160-F6){ref-type="fig"}*A*). F[ig]{.smallcaps}. 6.---Genomic features and a possible evolutionary process of the pSMC1 multidrug-resistant plasmid of SM39. (*A*) Genomic comparison of pSMC1 and p07-406, an IncP plasmid of *Pseudomonas aeruginosa*. Although significant differences were observed in the region corresponding to a Tn*501*-like transposon and the region corresponding to an integron-carrying transposon, the backbones of the two plasmid genomes are nearly identical and their GC content is significantly higher than that of the *Serratia marcescens* chromosomes and rather similar to that of *Pseudomonas* species, suggesting that pSMC1 originated from *Pseudomonas* species. (*B*) Structural comparison of the integron of pSMC1 with that on pK29 of *Klebsiella pneumoniae*. The difference in genetic structure between the two integrons could be generated by two inversion events and by insertion of IS elements and acquisition/duplication of several genes.

Comparison of a pSMC1-cured SM39 derivative (KS3) with the wild type showed that the high level of resistance displayed by SM39 to beta-lactams, aminoglycosides and mercury is accounted for by the presence of pSMC1. Compared with SM39, KS3 was great or equal to four more sensitive to 22 of the 36 antimicrobial agents tested; 14 of the 16 beta-lactams, all of the seven aminoglycosides, and to mercury. The 14 beta-lactams included carbapenems, the resistance to which is attributable to MBL. The exception is resistance to fluoroquinolones, which, as mentioned above, is attributable to the chromosomal mutation in *gyrA* ([table 3](#evu160-T3){ref-type="table"}).

Plasmid pSMC1 exhibits a remarkable similarity to an IncP plasmid of *Pseudomonas aeruginosa,* p07-406 ([@evu160-B37]) ([fig. 6](#evu160-F6){ref-type="fig"}*A*). The backbones of the two plasmids encoding the *tra* region and replication functions are nearly identical in gene compliment and with a GC content (64.1--66.1%) characteristic of pseudomonads. The main differences concern their genetic cargo encoding multiple drug resistance. This is consistent with the notion that *Pseudomonas* species are the original hosts for IncP plasmids with high GC backbones ([@evu160-B69]). However, as the integron-containing region of pSMC1 is also high similarity to that on plasmid pK29 of *Klebsiella pneumoniae* ([@evu160-B6]) although complex rearrangements including inversion and gene duplication have occurred, it suggests that these closely related plasmids have become widely disseminated in the *Enterobacteriaceae* ([fig. 6](#evu160-F6){ref-type="fig"}*B*).

Concluding Remarks
==================

We selected two *S. marcescens* strains from contrasting sources in an attempt to maximize our ability to capture the genomic diversity of this ubiquitous enteric species. Through our comparative analysis, we have defined a core genome of *S. marcescens* as well as that of the genus, although it should be noted that the latter gene set was generated from free-living *Serratia* species only. The former gene set defines the intrinsic metabolic capacities, virulence, and multidrug resistance of this opportunistic pathogen. Analysis of strain-specific genes or genomic regions has further revealed a high level of genomic diversity and plasticity of *S. marcescens*, which reflects the diversity of niches that this species can occupy. In fact, among the SM39-specific genes, many genes that are implicated in the high virulence potential of this clinical isolate have been identified, this includes many virulence-related genes found within the core genome of *S. marcescens*. Furthermore, analysis of the pSMC1 plasmid of SM39 has revealed that it encodes MBL and many other drug resistance determinants and is responsible for the extremely high level of multidrug resistance of the strain. We were able to propose a possible origin and evolution of pSMC1 on the basis of its genomic features. These data, combined with available tools for functional genomic analysis such as that described by [@evu160-B75], will accelerate research on *S. marcescens* in numerous domains and provide new insights into the genetic mechanisms responsible for the emergence of pathogens highly resistant to multiple antimicrobial agents.

Supplementary Material
======================

[Supplementary figures S1--S5](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1) and [tables S1--S9](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu160/-/DC1) are available at *Genome Biology and Evolution* online (<http://www.gbe.oxfordjournals.org/>).
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[^3]: ^a^The number of pseudogenes is indicated in parentheses.

[^4]: ^a^Similar to the NodT family protein but contains no membrane-spanning domain.

[^5]: N[ote]{.smallcaps}.---PEN, penicillin; PEM, penem; 1st CEP, 1st generation cephalospoin; 2nd CEP, 2nd generation cephalospoin; 3rd CEP, 3rd generation cephalospoin; 4th CEP, 4th generation cephalospoin; MONO, monobactam; CARB, carbapenem.

[^6]: ^a^KS3 is a pSMC1-cured SM39 derivative.

[^7]: ^b^The *rpsL* gene of Db11 contains a point mutation which confers streptomycin resistance on this strain.

[^8]: ^c^Mutation in *gyrA*. The S83R mutation in the quinolone resistance-determining region.
